Juan Carlos Lacal

Prof. Juan Carlos Lacal

Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas, 28029 Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2002 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
AMAna Ramírez de Molina
Ana Ramírez de Molina
ARAgustı́n Rodrı́guez-González
Agustı́n Rodrı́guez-González
RGRuth Gutiérrez
Ruth Gutiérrez
LMLuis Martı́nez-Piñeiro
Luis Martı́nez-Piñeiro
JSJosé J Sánchez
José J Sánchez
JLJuan Carlos Lacal
Juan Carlos Lacal

19 November 1987 in Nature
Verified
Journal Article
Open access
PDF file
JLJuan Carlos Lacal
Juan Carlos Lacal
JMJorge Moscat
Jorge Moscat
SAStuart A. Aaronson
Stuart A. Aaronson
Genes involved in the transduction of signals required for normal cell proliferation commonly appear to be subverted in the neoplastic process1. One such group is the highly conserved family of ras genes, which have been detected as transforming genes in a wide variety of naturally occurring tumours. By analogy with other known G proteins2, the p21 proteins encoded by ras genes may act as regulatory proteins in the transduction of signals that lead to DNA synthesis. A major pathway involved in the DNA synthesis induced by growth factors is mediated by phosphatidylinositol turnover: cleavage of phosphoinositides by phospholipase C produces 1,2-diacylglycerol, and inositol phosphates3. The former acts as an essential cofactor for protein kinase C (ref. 4), and inositol-(l,4,5)-triphosphate mobilizes Ca2+ from non-mitochondrial intracellular stores5. We demonstrate a reproducible increase in 1,2-diacylglycerol, in the absence of a detectable increase in inositol phosphates, in transformed cells containing Ha-ras oncogenes and with different membrane targeting signals for the ras p21 protein. These findings suggest that a source other than phosphoinositides exists for the generation of 1,2-diacylglycerol and that the Ha-ras oncogene specifically activates this novel pathway for 1,2-diacylglycerol production.

1 April 2001 in Cancer Letters
Verified
Journal Article
Closed access
SASalvador Aznar
Salvador Aznar
JLJuan Carlos Lacal
Juan Carlos Lacal

1 June 2019 in Cell Metabolism
Verified
Journal Article
Closed access
ESElsa Sanchez-Lopez
Elsa Sanchez-Lopez
ZZZhenyu Zhong
Zhenyu Zhong
ASAlexandra Stubelius
Alexandra Stubelius
SSShannon R. Sweeney
Shannon R. Sweeney
LBLaela M. Booshehri
Laela M. Booshehri
MKMichael Karin
Michael Karin

14 June 2002 in Oncogene
Verified
Journal Article
Closed access
PDF file
AMAna Ramírez de Molina
Ana Ramírez de Molina
RGRuth Gutiérrez
Ruth Gutiérrez
MRMaria Angeles Ramos
Maria Angeles Ramos
JSJosé María Silva
José María Silva
JSJavier Silva
Javier Silva
JLJuan Carlos Lacal
Juan Carlos Lacal

12 May 2005 in BioEssays
Verified
Journal Article
Closed access
PDF file
DPdel Pulgar
del Pulgar
TGTeresa Gómez
Teresa Gómez
SBSalvador A. Benitah
Salvador A. Benitah
PVPilar F Valerón
Pilar F Valerón
PFPilar F.
Pilar F.
JLJuan Carlos Lacal
Juan Carlos Lacal